Not applicableStudy completedNCT02261649What this trial is testingImpact of Cerebellar Mass Resection on Pain ProcessingWho this might be right forCerebellar Neoplasm Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00057811What this trial is testingRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more Children's Oncology Group 97
Early research (Phase 1)Study completedNCT04330664What this trial is testingAdagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplastic Disease Mirati Therapeutics Inc. 86
Not applicableActive Not RecruitingNCT05236764What this trial is testingHaploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 DepletionWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more Baylor College of Medicine 3
Early research (Phase 1)Not Yet RecruitingNCT07110363What this trial is testingA Clinical Study of BT02 in Treating Patients With Advanced Lung CancerWho this might be right forAdvanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more Biotroy Therapeutics 58
Testing effectiveness (Phase 2)Study completedNCT02113800What this trial is testingSafety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II StudyWho this might be right forPoorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more AIO-Studien-gGmbH
Testing effectiveness (Phase 2)Study completedNCT00002931What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell CancerWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more City of Hope Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT00564733What this trial is testingFDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer University of Washington 55
Testing effectiveness (Phase 2)Study completedNCT00485225What this trial is testingOpen Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic PainWho this might be right forChronic, Non Malignant Pain Durect 77
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Large-scale testing (Phase 3)Ended earlyNCT00858364What this trial is testingAnemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyWho this might be right forNon-Small Cell Lung CancerAnemiaCancer+1 more Amgen 2,549
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Not applicableStudy completedNCT00552825What this trial is testingPulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old ChildrenWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloblastic LeukemiaSolid Tumors,+2 more Sheba Medical Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT01050855What this trial is testingReduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant DisordersWho this might be right forNon Malignant DiseasesImmunodeficienciesHemoglobinopathies Children's Hospital of Philadelphia 75
Not applicableStudy completedNCT01899976What this trial is testingX-MAS Biliary Study With Covered Biliary StentWho this might be right forBiliary Tract Cancer Medinol Ltd. 68
Large-scale testing (Phase 3)Looking for participantsNCT06294691What this trial is testingEffect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic DiseasesWho this might be right forAcute Graft-versus-host Disease Anhui Provincial Hospital 198
Not applicableLooking for participantsNCT05231135What this trial is testingA Registry Study on HIV-related LymphomaWho this might be right forAIDS Related LymphomaHIV Related Lymphoma Rotkreuzklinikum München gGmbH 300
Testing effectiveness (Phase 2)UnknownNCT00384410What this trial is testingUse of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain PatientsWho this might be right forPainInsomnia University Health Network, Toronto 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Not applicableEnded earlyNCT02566421What this trial is testingGenomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by SurgeryWho this might be right forMetastatic NeoplasmRecurrent NeoplasmRecurrent Non-Small Cell Lung Carcinoma+4 more Wake Forest University Health Sciences 110